Skip to main content
Clinical Trials/NCT02859818
NCT02859818
Unknown
Not Applicable

Description of the Evolution of a Cohort of Adolescents With Type 1 Diabetes Following Their Participation in Therapeutic Education Program Based on Social Cognitive Theory: Socio-cognitive Profile, Physiological Behaviour of Therapeutic Adherence and Quality of Life

Assistance Publique Hopitaux De Marseille1 site in 1 country168 target enrollmentDecember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 1 Pediatric Diabetes
Sponsor
Assistance Publique Hopitaux De Marseille
Enrollment
168
Locations
1
Primary Endpoint
Self-efficacy evaluated with the 10 items-SEDM
Last Updated
9 years ago

Overview

Brief Summary

Introduction: Therapeutic Patient Education (TPE) is the key of the interdisciplinary management of type 1 diabetes for adolescents, favoring their adherence and improving their quality of life and metabolic control. Six pediatric diabetes teams have engaged in action research to build a regional ETP program based on social cognitive theory of Bandura, assuming that the learning strategies of theory, applied in ETP program, should strengthen self-efficacy of adolescents with type 1 diabetes, which could induce an improvement behaviors adherence, quality of life and physiological profile of participants about 6 months post-inclusion in the program.

Aims: The main objective is to describe the evolution over 6 months of self-efficacy in a cohort of adolescents with type 1 diabetes who followed a therapeutic education program based on social cognitive theory of Bandura in region PACA (ETPACAP program). Secondary objectives are to describe the evolution of 6 months of glycemic control, behavior of adherence, quality of life and other components of social cognitive theory for this population, to explore the effects of socio-cognitive profile on adherence, quality of life and glycemic control among adolescents with type 1 diabetes followed this program.

Method: A prospective multicenter cohort study of adolescents with type 1 diabetes who participated in ETPACAP program, consisting of three components:

  • A quantitative component: collection and analysis of changes over 6 months of self-efficacy, adherence, quality of life and HbA1c levels (ANOVA repeated measures);
  • A qualitative component: interviews with 32 participants at M0, M3 and M6 on the socio-cognitive factors according to Bandura (analysis continues theming);
  • An integrative component, exploring the effects of the components of social cognitive theory on adherence, glycemic control and quality of life of adolescents with type 1 diabetes cohort.

Expected results: This research is expected to bring new knowledge about the ETP programs and the adolescent cohort studied to make an improvement and adjustment of educational sessions relevant to the needs and expectations of this population.

Registry
clinicaltrials.gov
Start Date
December 2016
End Date
May 2020
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Aged between 11 and 17 years inclusive;
  • Type 1 diabetes diagnosis confirmed by a doctor according to the diagnostic criteria;
  • More than 6 months in the disease;
  • Treatment with insulin for at least 6 months before the educational intervention;
  • Inclusion in the program ETPACAP;
  • Mastery of the French language written (elementary level)
  • Fluency in speaking the French language (elementary level)
  • Consent signed by the holders of parental authority and adolescents.

Exclusion Criteria

  • Pregnant women, parturient women or breastfeeding mothers (Article L.1121-5 of the Code of Public Health.)
  • Persons deprived of liberty by a judicial or administrative decision, those hospitalized without consent under articles L. 3212-1 and L. 3213-1 that do not fall under the provisions of Article L. 1121-8 of the Code of Public Health

Outcomes

Primary Outcomes

Self-efficacy evaluated with the 10 items-SEDM

Time Frame: 6 months

The self-efficacy will be evaluated with the 10 items-SEDM (Iannotti et al., 2006), translated into French by an adaptation process cross-cultural (linguistic validation and metrology)

Secondary Outcomes

  • Quality of life will be assessed using the KIDSCREEN-27(6 months)
  • Glycemic control: glycated hemoglobin (HbA1c)(6 months)
  • Adherence will be evaluated using 'the Diabetes Self-Management Profile "tool (DSMP)(6 months)
  • Outcome expectations, socio-structural factors and personal goals(6 months)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Determinants of Patients' Uptake of Therapeutic Education ProgrammeChronic DiseasePatient Education as TopicPatient AdherenceEmpathyQuality of Healthcare
NCT03255863University Hospital, Lille459
Completed
Not Applicable
Patient Therapeutic Education (PTE) in the rehabilitation process of stroke patients: improving self management and fostering transition from hospital to communityFirst stroke patients with mild/moderate to severe disabilityCirculatory SystemStroke, not specified as haemorrhage or infarction
ISRCTN75290225Regional Agency for Health and Social Care, Regione Emilia-Romagna185
Not yet recruiting
Not Applicable
Education Program in MyastheniaAuto-immune Myasthenia
NCT04714658University Hospital, Strasbourg, France100
Recruiting
Not Applicable
Impact of Patient's Therapeutic Education in APA and Dietetic on Radiotherapy Reproducibility Sessions for Prostate CancerProstate Cancer
NCT04832113Centre Leon Berard216
Completed
Not Applicable
Development and evaluation of a patient education intervention to improve health literacy (HL) for patients with chronic illnesschronic back pain (ICD-10: M47.1-M47.9, M48.1, M48.2, M48.8M48.9, M51.0-M51.9, M53.8, M53.9, M54.1, M54.3, M54.4, M54.5, M54.8, M54.9, F45.4)M15-M19M47.1M47.2M47.8M47.9M48.1M48.2M48.8M48.9M51.0M51.1M51.2M51.3M51.4M51.8M51.9M53.8M53.9M54.1M54.3M54.4M54.5M54.8M54.9F45.4ArthrosisOther spondylosis with myelopathyOther spondylosis with radiculopathyOther spondylosisSpondylosis, unspecifiedAnkylosing hyperostosis [Forestier]Kissing spineOther specified spondylopathiesSpondylopathy, unspecifiedLumbar and other intervertebral disc disorders with myelopathyLumbar and other intervertebral disc disorders with radiculopathyOther specified intervertebral disc displacementOther specified intervertebral disc degenerationSchmorl nodesOther specified intervertebral disc disordersIntervertebral disc disorder, unspecifiedOther specified dorsopathiesDorsopathy, unspecifiedRadiculopathySciaticaLumbago with sciaticaLow back painOther dorsalgiaDorsalgia, unspecifiedPersistent somatoform pain disorder
DRKS00000655niversitätaklinikum Freiburg Institut für Qualitätsmanagement und Sozialmedizin1,473